2020 CSL Research Acceleration Initiative Awardees Announced

Learn More

CSL Dispatches First Australian Made Doses of the AstraZeneca COVID 19 Vaccine

Learn More

Our 2021 Half Year Financial Results information and webcast recording is now available

Learn More

Popular search terms:

Paul Perreault

COVID-19: A Message from Our CEO

"As the COVID-19 pandemic evolves, CSL remains committed to safeguarding our patients, our donors and our people. In keeping with our values-based culture, CSL has taken precautions to ensure our employees and our facilities remain safe so we can continue to deliver on our promise to patients and public health." - Paul Perreault, CEO & Managing Director, CSL Limited

CSL Logo

CSL welcomes domestic mRNA vaccine development

Onshore mRNA manufacturing will build Australian capability for next generation vaccine technologies

12 May 2021
CSL Logo

CSL welcomes the Patent Box Policy

New Patent Box policy will benefit domestic commercialisation of medical research

12 May 2021
red text logo for CSL Behring

CSL Behring Announces Agreement with uniQure

Etranacogene dezaparvovec (AMT-061) is an investigational gene therapy that may potentially provide people with hemophilia B …

06 May 2021

Get to Know Us Better

Scientists in Marburg, Germany
Analytical Services Quality Employee Angelika Jung

Angelika Jung

Senior Manager, ASQ Group Leader External Materials & Sampling (Marburg, Germany)

Angelika has been with CSL Behring for nearly 20 years and in that time has grown from having no direct reports to leading a large team in our Quality group.

Watch Angelika's Story